Dr. Maly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3991 Dutchmans Ln
Ste 405
Louisville, KY 40207Phone+1 614-293-3989- Is this information wrong?
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2017
- Ohio State University HospitalResidency, Internal Medicine, 2011 - 2014
- Lewis Katz School of Medicine at Temple UniversityClass of 2011
Certifications & Licensure
- IN State Medical License 2017 - 2025
- KY State Medical License 2017 - 2025
- OH State Medical License 2011 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection Start of enrollment: 2020 Aug 14
- A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms Start of enrollment: 2020 Dec 21
Publications & Presentations
PubMed
- 6 citationsOral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised...Garcia-Manero, G., McCloskey, J., Griffiths, E., Yee, K., Zeidan, A., Al-Kali, A., Deeg, H., Patel, P., Sabloff, M., Keating, M., Zhu, N., Gabrail, N., Fazal, S., Maly...> ;The Lancet. Haematology. 2024 Jan 1
- 55 citationsVenetoclax Plus Gilteritinib for-Mutated Relapsed/Refractory Acute Myeloid Leukemia.Naval Daver, Alexander E Perl, Joseph Maly, Mark Levis, Ellen Ritchie, Mark Litzow, James McCloskey, Catherine C Smith, Gary Schiller, Terrence Bradley, Ramon V Tiu, K...> ;Journal of Clinical Oncology. 2022 Dec 10
- 11 citationsENGINE: a Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic...Grzegorz S. Nowakowski, Jun Zhu, Qingyuan Zhang, Joshua Brody, Xiuhua Sun, Joseph Maly, Yuqin Song, Syed Rizvi, Yongping Song, Frederick Lansigan, Hongmei Jing, Junnin...> ;Future Oncology. 2020 Apr 6
- Join now to see all
Abstracts/Posters
- Venetoclax in Combination with Gilteritinib in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Phase 1b StudyClinically Relevant AbstractJoseph Maly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ...Joseph Maly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Hospital Affiliations
- Norton HospitalLouisville, Kentucky
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: